Featuring PASV Valve and Endexo technology, the BioFloTM PASV PICC is shown to reduce catheter occlusions by 78% 1 and thrombus accumulation by 87% 2.
1 Burns, D. Retrospective Analysis The Vanderbilt PICC service: Program, Program, Procedural and Patient Outcomes Success, Vanderbilt University. JAVA Vol.10 No. 42005
2 In vitro blood loop model test results demonstrated on average 87% less thrombus accumulation.
BioFlo is a trademark of AngioDynamics® and is distributed by Kimal PLC in the UK and Germany.